In these experiments, the ERβ agonists displayed bell-shaped responses with growth inhibition at low doses and opposite effect at high doses, as previously reported for cholangiocarcinoma and mesothelioma cells [14,20]. The gene discussed is ESR2; the disease is mesothelioma.